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ABSTRACT
OBJECTIVES: To explore the association between adiposity, major depressive disorder and 
generalized anxiety disorder, and to assess the role of inflammation, diet quality and physical 
activity in this association.
METHODS: We used data from 2,977 individuals from the 1993 Pelotas Cohort (Brazil) who 
attended the 18- and 22-year follow-ups. We assessed general obesity using body mass index, 
fat mass index, and abdominal obesity using waist circumference. Major Depressive Disorder 
and generalized anxiety disorder were assessed using the mini-international neuropsychiatric 
interview. C-reactive protein and interleukin-6 (IL-6) levels were used as a measure of 
inflammation; diet quality was estimated using the revised diet quality index, and physical 
activity was assessed by the International physical activity questionnaire (IPAQ, min/day). The 
association between adiposity and major depressive disorder and generalized anxiety disorder 
was assessed using logistic regression, and the natural indirect effect via the mediators was 
estimated using G-computation.
RESULTS: General obesity assessed by body mass index (OR: 2.3; 95% CI:1.13; 4.85), fat mass index 
(OR: 2.6; 95%CI: 1.37; 4.83), and abdominal obesity (OR: 2.5; 95%CI: 1.18; 5.39) were associated 
with higher odds of major depressive disorder, whereas major depressive disorder was only 
associated with obesity assessed by body mass index (OR=1.9; 95% CI: 1.09; 3.46). Obesity and 
generalized anxiety disorder were not associated. C-reactive protein, diet quality and physical 
activity did not mediate the effect of obesity on major depressive disorder, and C-reactive protein 
mediated about 25% of the effect of major depressive disorder on adiposity.
CONCLUSIONS: Depression, but not generalized anxiety disorder, is associated with adiposity 
in both directions, with a stronger evidence for the direction obesity-depression. Inflammation 
explains part of the effect of major depressive disorder on obesity but not the other way around. 
Further research should explore other mechanisms that could be involved in the association 
between obesity and depression.
DESCRIPTORS: Adiposity. Obesity. Depression. Anxiety Disorders. Measures of Association, 
Exposure, Risk or Outcome.
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INTRODUCTION
Emerging adulthood (18 to 29 years old) is a critical life period of high instability, when most people 
have not yet set up the stable structure of an adult life. Obesity and mental disorders are common 
during this period1,2, and are associated with the occurrence of several chronic diseases later in life3,4.
Several meta-analyses of cohort studies showed a bidirectional association between major 
depressive disorder (MDD) (symptoms and clinical diagnosis) and obesity in adolescents 
and adults, and the direction from depression to obesity seems to be more common than the 
opposite5-7. The effect of abdominal obesity on MDD might be higher than the effect of general 
obesity8, and the association between depressive symptoms with changes in abdominal 
visceral fat has been shown to be stronger than that with changes in overall obesity9. However, 
the evidence currently available comes from high-income countries (HIC), which limits the 
extrapolation of results to low- and middle-income countries (LMIC) since differences in 
sociocultural characteristics and lifestyle behaviors could affect such association.
The bidirectional association between anxiety and obesity has been less investigated. A 
prospective study with 3,134 adolescents in the United States showed that anxiety disorders 
predicted overweight/obesity, but not the opposite; in addition, this effect was observed 
only in males10. Evidence regarding generalized anxiety disorder (GAD) and obesity is also 
weak, and the only study assessing the bidirectional relationship between body mass index 
(BMI) and GAD found no association, in any direction11.
Several genetic, biological, social, psychological and behavioral factors could explain 
the interrelationship between obesity and depression/anxiety12,13. One of the biological 
mechanisms is immune-inflammatory activation, as both individuals with obesity and 
depression have increased inf lammatory markers, such as C-reactive protein (CRP), 
interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α)12. Some modifiable lifestyle 
behaviors, such as decreased levels of physical activity and unhealthy diet, are associated 
with a higher risk of both obesity and depression/anxiety, and could also be involved in 
such association12,13. These mechanisms, however, remain understudied.
Using data from a birth cohort in a middle-income country (Brazil), this study aimed to 
explore the directionality of the association between adiposity and MDD/GAD, as well as 
to assess the role of inflammation (CRP and IL-6 level) and lifestyle behaviors (diet quality 
and physical activity) in young adults.
METHODS
Study design and participants
Data from the 1993 Pelotas Cohort were used. In that year, all maternity hospitals in the city of 
Pelotas were visited daily and births were identified. Livebirths whose family lived in the urban 
area of the city were examined and their mothers interviewed (less than 1% of the deliveries were 
at home or other places). A total of 5,265 births were recorded, and 5,249 children participated in 
the study. Such subjects have been prospectively followed-up, and subsamples of the participants 
were attained until they reached the age of 11, when the full cohort was contacted. Follow-ups of 
the full cohort took place at 11, 15, 18 and 22 years of age. After the 18-year follow-up, interviews 
took place at the research clinic instead of at home. The response rate at 18 and 22 years old was 
81.4% and 76.3%, respectively. Further details on study methodology are available elsewhere14,15.
Measures
Depression and anxiety
The MDD and GAD were assessed at the 18- and 22-year follow-ups using the Mini 
International Neuropsychiatric Interview (MINI), version 5.016. This instrument was 
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applied by trained psychologists and was validated for the Brazilian population17. Mental 
disorders definitions followed the DSM-5 criteria, and individuals were diagnosed with 
current GAD and MDD if they had presented symptoms in the 6 months and 15 days prior 
to the interview, respectively, in addition to moderate or severe levels of impairment. 
Impairment was assessed through the following question: “Thinking about your life, 
school, work, home, family and friends, how much have these problems impaired you? 
The answer options were: no impairment (0), mild impairment (1), moderate impairment 
(2), or severe impairment (3). Neuropsychiatric interview was not performed with 
deaf-mute individuals or with those with cognitive disability (n=3 at 18 years old and 
n=19 at 22 years old).
Adiposity
At the 18- and 22-year follow-ups, a detailed assessment of body composition was performed, 
which included anthropometric measures and dual X-ray absorptiometry (DXA; GE Medical 
Systems Lunar). Body composition evaluation was carried out by trained and standardized 
assessors. For the examinations, participants wore tight-fitting gym suits (shorts and 
sleeveless top) and were barefoot. Exams were not performed in women who were pregnant 
or suspect to be pregnant and individuals with physical problems (wheelchair users and 
individuals with osteoarticular deformities). For DXA examination, those with weight over 
120 kg or height over 192 cm (maximum device capacity), and those who had implanted 
metal pins, screws, plates and non-removable metallic objects (body piercings and/or 
chains) were not evaluated.
In this study, BMI and fat mass index (FMI) were used as indicators of total adiposity, and 
waist circumference (WC) as a measurement of central adiposity. Height was measured 
twice, using an aluminum stadiometer with accuracy of 1mm, and the mean of the two 
measurements was used. Weight was measured with an accuracy of 10g, using an electronic 
scale connected to BodPod®. The BMI was calculated dividing total weight (kg) by height 
squared (m2). WC was measured at the narrowest point of the waist, with a flexible tape, 
to the nearest 1mm. FMI was calculated by dividing total fat mass (kg), obtained by DXA, 
by height squared (m2).
General obesity was defined according to both BMI (≥ 30 kg/m2) and FMI (> 9 for men and 
> 13 for women)18. Abdominal obesity was defined as WC ≥ 88 cm for women and WC ≥ 102 for 
men. Continuous measures of BMI, FMI and WC were also used for sensitivity analysis.
Mediators: inflammation, diet quality and physical activity
CRP (mg/L) e IL-6 (pg/ml), diet quality, and physical activity level in leisure time or 
commuting, all assessed at the 18-y follow-up, were used as possible mediators.
To assess CRP and IL-6 concentration, non-fasting blood samples were collected by 
venipuncture, using vacutainer tubes. All samples were processed in the laboratory, stored 
in the same freezers at ultra-low temperature and registered in a central bio-repository. The 
CRP was measured by immunoturdimetric assay (Labtest Diagnóstica SA, Minas Gerais, 
Brazil), whereas IL-6 was measured using the Quantikine® HS Human IL-6 immunoassay kit 
(R&D Systems®, Inc.; Minneapolis, MN55413, USA). As CRP and IL-6 were asymmetrically 
distributed, they were log-transformed to obtain normalized residuals.
Total caloric intake was assessed using a food frequency questionnaire with 88 items19. Diet 
quality was estimated using the revised diet quality index, as previously described20, and 
analyzed as a continuous variable.
Physical activity level in leisure time and commuting (min/day) was self-reported, using 
the long version of the IPAQ21; hence, individuals were classified as active (> 150 minutes) 
or insufficiently active (< 150 minutes).
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Base confounders (confounders of the association between mental disorders and adiposity)
At the perinatal visit, the following variables were assessed: sex (male/female); family income 
(earned by family members in the month before the interview); mother’s education level 
(complete years), age (years), smoking during pregnancy (yes/no), alcohol intake during 
pregnancy (yes/no) and pre-pregnancy BMI (calculated using self-reported weight and height); 
birth weight (measured in grams). Maternal smoking and alcohol intake in pregnancy were 
defined as any reported use of cigarettes or alcohol, respectively, at any time during pregnancy. 
Maternal mental health was measured at the 11-year follow-up using the short version of 
the Self-Reporting Questionnaire (SRQ-20)22.  At the 15-year follow-up, information on the 
participant’s self-reported skin color (white, black/brown, yellow/indigenous), alcohol use 
(yes/no) and tobacco use in the previous month (yes/no) were assessed. Parenthood (yes/
no) was assessed at the 18-year follow-up.
Intermediate confounders (confounders of association between each mediator and the outcome)
For mediation analysis by physical activity, diet quality at 18 years of age was considered 
as intermediate confounder. For the mediation analysis by diet quality, physical activity 
at 18 years old was considered an intermediate confounder, whereas for the mediation 
analysis by inflammation markers, diet quality and physical activity were both considered 
intermediate confounders.
Statistical Analysis
Analyses were conducted using Stata, version 12.1 (Stata Corp., College Station, TX, USA). To 
assess the association between mental disorders and adiposity, logistic regression models 
were performed considering each direction, with and without adjustment for the potential 
base confounders defined above. In all analyses, those who had the outcome of interest at 
18 years old were excluded to reduce the probability of reverse causality. Supplementary 
analyses were performed using continuous measures of adiposity, considering all 
participants. Standard deviations were used when adiposity was assessed as exposure, and 
changes in the adiposity measure between 18 and 22 years old were used when assessing 
it as the outcome. Tests were carried out for interactions between sex and each exposure, 
and no evidence was found (all p-values > 0.05).
Mediation analyses were performed using G-computation with 10,000 bootstrap replications, 
to estimate the natural indirect effect (NIE) ‒ mediated effect ‒ of the association between 
mental disorders and adiposity. Each mediator was individually included on models so that 
NIE corresponds to the effect by each mediator separately, instead of including it all in the 
same model. All mediation analyses were adjusted for the base and intermediate confounders 
described above, considering possible interactions between exposures and mediators. The 
proportion mediated was calculated as: log(OR NIE)/log(OR Total effect) ×100%.
Ethical Considerations
All follow-ups were approved by the Medical Ethics Committee of the Federal University 
of Pelotas, and participants or their legal caregivers voluntarily signed an informed 
consent form prior to participating in the study. Individuals with high suicidal risk in the 
neuropsychiatric interview were referred to health services.
RESULTS
Sample Characteristics
This study sample size comprised 2,977 participants who had complete information on 
MDD/GAD and adiposity measures at both the 18-year and 22-year follow-ups. Compared 
to those excluded from analysis, the included were more likely to be female, to have lower 
5Depression, anxiety and adiposity association Gomes AP et al.
https://doi.org/10.11606/S1518-8787.2019053001119
socioeconomic status (lower family income and maternal education level), and to have 
better health indicators, e.g. lower prevalence of maternal smoking during pregnancy, 
common maternal mental disorders, and adolescent smoking at the age of 15 (Data not 
showed in Table).
The prevalence of all obesity indicators and GAD were higher at 22 than at 18 years old, 
whereas the prevalence of MDD was higher at the age of 18 (Figure 1).
Association of obesity at 18 years old with MDD and GAD at 22 years old
After adjustment for confounders (Figure 2), all obesity measures were associated with 
higher odds of MDD, with a similar magnitude (OR varying from 2.3 to 2.6). No association 
between obesity and incidence of GAD was observed in both unadjusted or adjusted 
analyses. The same pattern of associations was observed using continuous measures of 
adiposity (data not showed in table).
Mediation of the association between adiposity and MDD
CRP, IL-6, diet quality, and physical activity did not seem to mediate the association between 
adiposity and MDD (Table 1).
Association of MDD and GAD at 18 years old with adiposity at 22 years old
The MDD was associated with higher odds of general obesity regarding to BMI, in both 
unadjusted (OR: 2.20; 95% CI: 1.20–3.73) and adjusted analyses (OR: 1.94, 95% CI: 1.09–3.46), 
but no association was found with other adiposity measures (Figure 3). No association was 
Figure 1. Prevalence of depression, anxiety and obesity in young adults of the 1993 Pelotas Cohort (n=2,977).
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observed between GAD and any obesity measure, in unadjusted or adjusted analyses. Similar 
results were observed when adiposity measures were assessed as continuous measures 
(data not showed in table).
Mediation of the association between MDD and adiposity
The CRP concentration explained about 25% of the association between MDD and obesity 
measured by BMI and no evidence was found for IL-6. Diet quality and physical activity did 
not mediate the association between MDD and adiposity measures (Table 2).
Table 1. Mediation by diet quality, physical activity level and inflammation markers of the association between adiposity and MDD.
Association Mediator¥
Natural direct effect
OR (95% CI)
Natural indirect effect
OR (95% CI)
Total effect
OR (95% CI)
Obesity (BMI)  MDD
Diet quality 2.76 (1.14–6.61) 0.92 (0.71–1.20) 2.55 (1.05–6.11)
Physical activity level 2.34 (0.96–2.72) 1.14 (0.89–1.47) 2.68 (1.11–6.49)
C-reactive protein level 1.95 (0.79–4.81) 1.05 (0.77–1.43) 2.06 (0.85–4.95)
IL-6 2.86 (1.14–7.09) 0.81 (0.60–1.11) 2.34 (0.98–5.53)
Obesity (FMI)  MDD
Diet quality 2.86 (1.33–6.11) 0.95 (0.74–1.22) 2.72 (1.26–5.81)
Physical activity level 2.42 (1.11–5.26) 1.14 (0.89–1.46) 2.76 (1.27–5.99)
C-reactive protein level 2.35 (1.06–5.21) 0.95 (0.70–1.28) 2.24 (1.03–4.48)
IL-6 3.16 (1.42–7.03) 0.80 (0.60–1.07) 2.53 (1.19–4.95)
Abdominal obesity (WC)  MDD
Diet quality 2.94 (1.19–7.24) 0.97 (0.75–1.25) 2.87 (1.14–7.17)
Physical activity level 2.63 (1.05–6.55) 1.11 (0.88–1.35) 2.94 (1.17–6.69)
C-reactive protein level 2.24 (0.88–5.47) 0.97 (0.71–1.32) 2.16 (0.87–5.37)
IL-6 3.32 (1.25–8.85) 0.74 (0.53–1.05) 2.46 (0.98–6.17)
¥ Each mediator was analyzed separately.
BMI: body mass index; FMI: fat mass index; GAD: generalized anxiety disorder; MDD: major depressive disorder; WC: waist circumference
All analyses were adjusted for mother’s age, pre-pregnancy BMI, education level, smoking in pregnancy, alcohol use in pregnancy, and family income at 
birth, sex, skin color, birth weight, maternal mental health at 11 years, tobacco and alcohol use at 15 years old and parenthood at 18 years of age.
BMI: body mass index; FMI: fat mass index; GAD: generalized anxiety disorder; MDD: major depressive disorder; WC: waist circumference
Figure 3. Association between major depressive disorder and generalized anxiety disorder at 18 years old, with incidence of BMI (A), FMI (B) 
and WC (C) between 18 and 22 years of age.
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DISCUSSION
The major findings of this study were: (1) a bidirectional association was found between 
MDD and obesity, even after accounting for many important, well-known confounders; 
(2) the effect of adiposity on MDD was stronger and more consistent than the effect of MDD 
on obesity; (3) GAD was not associated with obesity, and vice versa; (4) CRP, IL-6, physical 
activity and caloric intake did not mediate the effect of obesity on MDD, and CRP accounted 
for about 25% of the association between MDD and obesity (BMI).
Despite the various methods used to assess the bidirectionality of associations (longitudinal 
studies have used regression models, auto-regressive cross-lagged panel analyses and 
generalized estimating equations to access reciprocal risks), the bidirectional association 
between obesity and depression is consistent with the recent literature5-7,23. In previous 
studies, the OR varies from 1.2 to 3.8 when depression leads to obesity, and from 1.1 to 
5.8 when obesity leads to depression5,23. In our study, the effect of obesity on MDD was 
more consistent than in the opposite direction. A recent Mendelian randomization study 
(using genetic variants as instrumental variables) found that higher BMI predicts depressive 
symptoms but not the other way around, but the authors acknowledge the weakness of 
genetic instruments for instrumenting depression24. No difference by sex was observed in 
any of the associations, in accordance with previous meta-analyses5,7. However, one should 
note the effect of abdominal obesity on MDD seemed to be stronger in men, even though 
we had little power to detect such difference.
We found no evidence of mediation by IL-6 and CRP levels on the association of obesity 
leading to MDD, different from a previous cohort study with English older adults, which 
showed that CRP levels explained about 20% of the effect of obesity on depressive 
symptoms over a 4-year period of follow-up25. We found that about 25% of the MDD 
effect on obesity (BMI) was mediated by the CRP level, but no evidence of mediation 
was found with others adiposity measures or IL-6; Atypical MDD ‒ one distinct subtype 
of MDD that is characterized by reversed neurovegetative symptoms (i.e. increased 
appetite, leaden paralysis, and hypersomnia) ‒ has been frequently associated with 
high levels of inflammatory markers26 as well as obesity27, differently than melancholic 
MDD. Pro-inf lammatory cytokines, such as IL-6, are associated with heightened 
hypothalamic-pituitary-adrenal (HPA) axis activity, which can lead to elevated cortisol 
levels, which are known to increase appetite and preference for energy-dense food and to 
Table 2. Mediation analysis by diet quality, physical activity level and inflammation markers of the association between major depressive 
disorder and obesity (BMI).
Association
Mediator¥
OR (95% CI)
Natural direct effect
OR (95% CI)
Natural indirect effect
OR (95% CI)
Total effect
OR (95% CI)
MDD  Obesity (BMI)
Diet quality 2.12 (1.11–3.67) 0.96 (0.83–1.11) 2.01 (1.12–3.67)
Physical activity level 2.10 (1.16–3.78) 1.02 (0.88–1.18) 2.14 (1.19–3.67)
C-reactive protein level 1.67 (0.92–2.97) 1.20 (1.01–1.42) 1.99 (1.09–3.63)
IL-6 2.01 (1.12–3.60) 1.10 (0.94–1.29) 2.20 (1.21–4.06)
MDD  Obesity (FMI)
Diet quality 1.31 (0.68–2.51) 1.05 (0.90–1.23) 1.38 (0.72–2.63)
Physical activity level 1.45 (0.76–2.75) 1.03 (0.89–1.20) 1.49 (0.79–2.83)
C-reactive protein level 1.12 (0.59–2.12) 1.06 (0.90–1.25) 1.19 (0.63–2.28)
IL-6 1.30 (0.68–2.44) 1.13 (0.96–1.32) 1.45 (0.76–2.75)
MDD  Abdominal obesity (WC)
Diet quality 1.26 (0.55–2.86) 0.97 (0.79–1.20) 1.22 (0.54–2.75)
Physical activity level 1.32 (0.58–2.92) 1.08 (0.87–1.33) 1.42 (0.63–3.22)
C-reactive protein level 1.12 (0.50–2.63) 1.04 (0.83–1.31) 1.16 (0.51–2.63)
IL-6 1.30 (0.58–2.92) 1.12 (0.90–1.40) 1.46 (0.64–3.25)
¥ Each mediator was analyzed separately.
BMI: body mass index; FMI: fat mass index; GAD: generalized anxiety disorder; MDD: major depressive disorder; WC: waist circumference
Analyses was adjusted for the mother’s age, pre-pregnancy BMI and education level, maternal smoking in pregnancy, maternal alcohol use in pregnancy, 
family income at birth, sex, skin color, birth weight, maternal mental health at 11 years, tobacco and alcohol use at 15 years old and parenthood at 
18 years old.
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promote the accumulation of fat, especially in the abdominal region12. As the role of CRP 
level on MDD and obesity association was no consistent across all adiposity measures in 
our study, it is important that this hypothesis would be confirmed in others longitudinal 
studies to rule out that this result was observed by chance.
Our study did not confirm the hypothesis that decreased levels of physical activity and 
consumption of low-quality diet mediated the association between obesity and MDD. We 
further considered other diet indicators (i.e. consumption of ultraprocessed foods and 
caloric intake at 18 years old), and results were similar (data not shown in this paper). A 
cross-sectional study using data from National Health and Nutrition Examination Surveys 
in the United States showed that physical activity mediated 79% of the effect of MDD on BMI 
in young adults, but diet quality was not involved in this association28. A longitudinal study 
carried out with female Mexican health workers, exploring the bidirectional association 
between depression and body fat, showed that higher caloric intake and lower physical 
activity in leisure time mediated the effect of depressive symptoms on body fat, and no 
effects of obesity on depression were found29. In our data, obesity was associated with higher 
physical activity, contrary to what would be expected, which could explain the lack of an 
indirect effect by this variable. Although counterintuitive, this association may be explained 
by a tendency of over-reporting physical activity among obese people, so we cannot rule out 
that information bias led to this result. Moreover, the exposures and mediators variables 
are both collected in the same follow-up and reverse causality may be present, masking 
the indirect effect these variables may have in the reciprocal association of adiposity and 
the mental disorders evaluated.
One important mechanism that could explain why depression is related to a higher risk 
of obesity is the use of antidepressant drugs. We intended to test such association, but the 
prevalence of antidepressant drug use at 18 years old in our sample was only 0.7%, and 
antidepressants use was not associated with obesity. Hence, it is unlikely that the effect of 
MDD on obesity would be completely attributable to antidepressant drugs use in our data. 
We acknowledge that other mechanisms linking MDD and adiposity, such as inadequate 
sleep, low self-esteem, body image dissatisfaction, binge eating/emotional eating, and 
experience of weight-related or MDD-related stigma13, were not explored in this study and 
require further investigation.
Although plausible, the association between anxiety and adiposity has been poorly 
investigated. The mechanisms are very similar to those linking MDD and obesity. Biological 
mechanisms included the possibility of sharing a common genetic basis and HPA axis 
dysregulation30. Weight discrimination, poorer social support and social networks could 
increase the risk of anxiety in obese individuals30. The pressure to gain control over their 
weight could be distressing for obese people and increase the risk of anxiety, particularly 
when many attempts to lose weight have failed30. Symptoms of anxiety may increase appetite 
and the preference for and consume of palatable “comfort foods” as a mean to alleviate their 
negative feelings and may, as consequence, lead to obesity31.
This study did not show any association between obesity and GAD, corroborating a previous 
bidirectional study on this same association11. Even though some studies have found a 
positive association between anxiety disorders and obesity (BMI)30, such association might 
be related to specific anxiety disorder other than GAD. Future prospective studies should 
test the effect of other types of anxiety disorders and their association with adiposity.
Our study has several strengths. First, we used data from a birth cohort carried out in a 
middle-income country, where this association has been poorly investigated. We could 
examine directionality of effects in the same population, using the same instruments. 
Besides BMI, we also used different and more accurate measures of adiposity and were 
able to control for several relevant confounders, such as birth weight, maternal BMI and 
maternal common mental disorders, often not accounted for in previous studies.
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Nevertheless, results of this study should also be considered in the context of several 
limitations. We were able to complete assessments with 56.7% of the original cohort, raising 
the possibility of non-response bias. Those excluded from the analysis were more likely to 
have lower socioeconomic status, which is associated with higher prevalence of mental 
disorders and obesity in our data. Therefore, we expect that associations reported here 
might be underestimated.
Although we excluded those with MDD and GAD at 18-year follow-up to reduce the 
probability of reverse causality, we cannot guarantee the cases were re-incident, as no 
information on previous diagnosis of MDD and GAD was available. Despite having high 
specificity, MINI is a screening tool and does not assess clinical diagnosis of mental disorders, 
so we might have misclassification error on the assessment of these disorders. However, the 
non-differential misclassification error is expected to underestimate associations. Finally, 
we were not able to distinguish between atypical and melancholic MDD, and some studies 
indicate that only individuals with atypical MDD have a higher risk of obesity.
This study suggests a bidirectional association between obesity and MDD. CRP level mediated 
about 25% of the effect of MDD on adiposity, whereas diet quality and physical activity had 
no indirect effect in this relationship. The GAD-obesity association was not confirmed in this 
study, but evidence of this association in other contexts should be investigated. Individuals 
with obesity and MDD could benefit from receiving a multidisciplinary treatment that 
includes psychological evaluation and weight gain monitoring, respectively. This could 
help prevent co-occurrence of these diseases and to better manage these conditions in 
those who already present both obesity and depression. Although we found no association 
with diet and physical activity in this analysis, a healthy lifestyle should be encouraged in 
these patients, as it could help obese individuals to lose weight and, consequently, alleviate 
depressive symptoms and reduce inflammatory markers that apparently can be involved 
in the association between MDD and obesity.
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